Cochrane COVID-19 Study Register
Study record
NCT04918901First Published: 2021 Jun 10Updated Date: 2021 Jun 10

Comparative Analysis of Clinical Indicators and Imaging Changes of Severe COVID-19

  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
Reference record

Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19

Second Affiliated Hospital, School of Medicine, Zhejiang University
First Published (first received 2021 June 09)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT04918901)
Trial registry record
No Results
Novel Coronavirus Pneumonia (COVID-19) is the pneumonia caused by the 2019 novel coronavirus infection. Critically ill patients with this disease develop dyspnea and hypoxemia, and even further aggravate acute respiratory distress syndrome, septic shock, coagulation dysfunction, and multiple organ failure. Since February 15, 2020, the 171-member medical team of the Second Affiliated Hospital of Zhejiang University School of Medicine has taken over the Intensive Care Unit of the Cancer Center of the Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology and the Intensive Care Unit of the West Hospital of Union Hospital to carry out severe and critical care. Treatment of patients with new coronary pneumonia. In clinical practice, combined with the changes in chest CT imaging of severe COVID-19 patients, it has been found that some laboratory indicators of severe patients can effectively judge the clinical prognosis and outcome of patients, but there is no relevant retrospective study with large sample size so far